|

AUTX-703 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Auron Therapeutics, Inc.1

Indications

  • Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)1
  • Refractory Myelodysplastic Syndromes1
  • Relapsed Myelodysplastic Syndromes1
  • Relapsed/Refractory AML1
  • Relapsed Acute Myeloid Leukemia (AML)1

Duarte, California1 trial

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

City of Hope National Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.